Clinical Trial Update: Prevention of Venous Thromboembolism in Subjects Undergoing Hip Fracture Surgery or Surgery in the Lower Extremities [Phase 3]

View source ↗

Summary

Phase 3 completed trial update from Astellas evaluating prevention of venous thromboembolism in patients undergoing hip fracture or lower-extremity surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Venous Thromboembolism | Phase 3 | Status: COMPLETED